Transaction in Own Shares

14th Nov 2025 07:00

RNS Number : 5145H
CVS Group plc
14 November 2025
 

14 November 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 13 November 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

13/11/2025

Aggregate number of Ordinary Shares purchased:

25,771

Lowest price paid per share (GBp):

1,150.00

Highest price paid per share (GBp):

1,186.00

Volume weighted average price paid per share (GBp):

1,163.79

CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 71,342,887 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 71,342,887 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 397,896 Ordinary Shares in aggregate at a weighted average price of 1,252.09 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 

264

1180

13/11/2025 08:01:14

1332290881849822

XLON

279

1184

13/11/2025 08:03:36

1332290881850507

XLON

73

1186

13/11/2025 08:08:18

1332290881852583

XLON

546

1186

13/11/2025 08:12:53

1332290881853796

XLON

647

1186

13/11/2025 08:12:53

1332290881853799

XLON

160

1184

13/11/2025 08:12:59

1332290881853814

XLON

104

1182

13/11/2025 08:14:06

1332290881854047

XLON

73

1184

13/11/2025 08:16:01

1332290881854402

XLON

180

1186

13/11/2025 08:23:19

1332290881856414

XLON

542

1184

13/11/2025 08:34:07

1332290881859364

XLON

92

1184

13/11/2025 08:34:07

1332290881859365

XLON

75

1186

13/11/2025 08:58:35

1332290881863693

XLON

42

1184

13/11/2025 09:04:05

1332290881864609

XLON

6

1184

13/11/2025 09:04:05

1332290881864610

XLON

108

1184

13/11/2025 09:04:05

1332290881864611

XLON

870

1180

13/11/2025 09:20:48

1332290881866730

XLON

918

1180

13/11/2025 09:25:59

1332290881867235

XLON

650

1180

13/11/2025 09:25:59

1332290881867240

XLON

195

1174

13/11/2025 09:29:49

1332290881867954

XLON

171

1174

13/11/2025 09:29:49

1332290881867957

XLON

280

1170

13/11/2025 09:45:34

1332290881869711

XLON

208

1168

13/11/2025 09:45:42

1332290881869726

XLON

121

1168

13/11/2025 09:45:42

1332290881869727

XLON

377

1164

13/11/2025 09:52:00

1332290881870571

XLON

25

1164

13/11/2025 09:52:01

1332290881870572

XLON

337

1164

13/11/2025 09:52:56

1332290881870643

XLON

1071

1162

13/11/2025 09:57:03

1332290881871070

XLON

234

1162

13/11/2025 09:57:03

1332290881871075

XLON

25

1162

13/11/2025 09:57:04

1332290881871076

XLON

435

1162

13/11/2025 09:57:05

1332290881871081

XLON

23

1162

13/11/2025 09:57:07

1332290881871092

XLON

435

1162

13/11/2025 09:59:01

1332290881871339

XLON

333

1162

13/11/2025 09:59:40

1332290881871422

XLON

1136

1164

13/11/2025 10:19:34

1332290881873843

XLON

7

1164

13/11/2025 10:19:34

1332290881873844

XLON

18

1164

13/11/2025 10:19:37

1332290881873853

XLON

200

1164

13/11/2025 10:27:13

1332290881874564

XLON

453

1164

13/11/2025 10:29:46

1332290881874880

XLON

682

1164

13/11/2025 10:29:46

1332290881874881

XLON

239

1166

13/11/2025 11:00:24

1332290881878956

XLON

754

1166

13/11/2025 11:00:24

1332290881878957

XLON

260

1164

13/11/2025 11:05:20

1332290881879626

XLON

130

1164

13/11/2025 11:05:20

1332290881879629

XLON

412

1160

13/11/2025 11:34:49

1332290881883132

XLON

165

1160

13/11/2025 11:34:49

1332290881883131

XLON

583

1160

13/11/2025 11:34:50

1332290881883133

XLON

11

1160

13/11/2025 11:34:51

1332290881883134

XLON

480

1160

13/11/2025 11:40:12

1332290881883811

XLON

679

1160

13/11/2025 11:40:12

1332290881883812

XLON

474

1158

13/11/2025 12:00:01

1332290881886345

XLON

744

1158

13/11/2025 12:00:01

1332290881886346

XLON

32

1156

13/11/2025 12:04:36

1332290881886885

XLON

6

1156

13/11/2025 12:06:32

1332290881887053

XLON

199

1156

13/11/2025 12:19:03

1332290881888184

XLON

16

1156

13/11/2025 12:19:04

1332290881888185

XLON

173

1156

13/11/2025 12:25:08

1332290881888750

XLON

296

1156

13/11/2025 12:25:08

1332290881888751

XLON

250

1156

13/11/2025 12:25:08

1332290881888752

XLON

846

1154

13/11/2025 12:38:37

1332290881890606

XLON

237

1154

13/11/2025 12:38:37

1332290881890609

XLON

17

1154

13/11/2025 12:38:40

1332290881890610

XLON

10

1154

13/11/2025 12:38:43

1332290881890615

XLON

244

1154

13/11/2025 12:38:43

1332290881890620

XLON

244

1152

13/11/2025 12:46:23

1332290881891454

XLON

315

1150

13/11/2025 13:01:04

1332290881893165

XLON

784

1152

13/11/2025 13:21:38

1332290881895168

XLON

89

1152

13/11/2025 13:21:38

1332290881895169

XLON

486

1152

13/11/2025 13:34:48

1332290881896556

XLON

107

1152

13/11/2025 13:34:48

1332290881896559

XLON

73

1152

13/11/2025 13:48:59

1332290881898345

XLON

1192

1154

13/11/2025 14:04:47

1332290881900058

XLON

24

1154

13/11/2025 14:04:47

1332290881900059

XLON

784

1152

13/11/2025 14:10:36

1332290881900752

XLON

157

1150

13/11/2025 14:14:44

1332290881901209

XLON

281

1150

13/11/2025 14:26:26

1332290881902602

XLON

202

1150

13/11/2025 14:26:26

1332290881902603

XLON

359

1150

13/11/2025 14:36:41

1332290881905436

XLON

198

1150

13/11/2025 14:36:41

1332290881905439

XLON

77

1150

13/11/2025 14:36:48

1332290881905461

XLON

354

1150

13/11/2025 14:52:57

1332290881909117

XLON

320

1150

13/11/2025 15:28:00

1332290881916539

XLON

73

1150

13/11/2025 15:28:00

1332290881916542

XLON

 

 

Contacts

CVS Group plc via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker) +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker) +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR) [email protected]

Ginny Pulbrook +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPGBUGUPAPGW